Symptoms and signs of urogenital cancer in primary care
- PMID: 37101110
- PMCID: PMC10131418
- DOI: 10.1186/s12875-023-02063-z
Symptoms and signs of urogenital cancer in primary care
Abstract
Background: Urogenital cancers are common, accounting for approximately 20% of cancer incidence globally. Cancers belonging to the same organ system often present with similar symptoms, making initial management challenging. In this study, 511 cases of cancer were recorded after the date of consultation among 61,802 randomly selected patients presenting in primary care in six European countries: a subgroup analysis of urogenital cancers was carried out in order to study variation in symptom presentation.
Methods: Initial data capture was by completion of standardised forms containing closed questions about symptoms recorded during the consultation. The general practitioner (GP) provided follow-up data after diagnosis, based on medical record data made after the consultation. GPs also provided free text comments about the diagnostic procedure for individual patients.
Results: The most common symptoms were mainly associated with one or two specific types of cancer: 'Macroscopic haematuria' with bladder or renal cancer (combined sensitivity 28.3%), 'Increased urinary frequency' with bladder (sensitivity 13.3%) or prostatic (sensitivity 32.1%) cancer, or to uterine body (sensitivity 14.3%) cancer, 'Unexpected genital bleeding' with uterine cancer (cervix, sensitivity 20.0%, uterine body, sensitivity 71.4%). 'Distended abdomen, bloating' had sensitivity 62.5% (based on eight cases of ovarian cancer). In ovarian cancer, increased abdominal circumference and a palpable tumour also were important diagnostic elements. Specificity for 'Macroscopic haematuria' was 99.8% (99.7-99.8). PPV > 3% was noted for 'Macroscopic haematuria' and bladder or renal cancer combined, for bladder cancer in male patients. In males aged 55-74, PPV = 7.1% for 'Macroscopic haematuria' and bladder cancer. Abdominal pain was an infrequent symptom in urogenital cancers.
Conclusions: Most types of urogenital cancer present with rather specific symptoms. If the GP considers ovarian cancer, increased abdominal circumference should be actively determined. Several cases were clarified through the GP's clinical examination, or laboratory investigations.
Keywords: Bladder cancer; Cervical cancer; General practice; Neoplasms; Ovarian cancer; Primary health care; Prostate cancer; Renal cancer; Urogenital cancer; Uterine body cancer.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Symptoms and signs of colorectal cancer, with differences between proximal and distal colon cancer: a prospective cohort study of diagnostic accuracy in primary care.BMC Fam Pract. 2021 Jul 8;22(1):148. doi: 10.1186/s12875-021-01452-6. BMC Fam Pract. 2021. PMID: 34238248 Free PMC article.
-
Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.BJU Int. 2012 Jul;110(1):84-94. doi: 10.1111/j.1464-410X.2011.10664.x. Epub 2011 Nov 28. BJU Int. 2012. PMID: 22122739
-
Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria.Scand J Urol. 2018 Aug;52(4):237-243. doi: 10.1080/21681805.2018.1498124. Epub 2018 Nov 9. Scand J Urol. 2018. PMID: 30411661
-
The diagnostic value of macroscopic haematuria in diagnosing urological cancers: a meta-analysis.Fam Pract. 1997 Feb;14(1):63-8. doi: 10.1093/fampra/14.1.63. Fam Pract. 1997. PMID: 9061347
-
Quality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic review.BMJ Open. 2019 Oct 3;9(10):e029143. doi: 10.1136/bmjopen-2019-029143. BMJ Open. 2019. PMID: 31585970 Free PMC article.
Cited by
-
The Association Between Anti-Neoplastic Effects of Curcumin and Urogenital Cancers: A Systematic Review.Biomed Res Int. 2024 Oct 15;2024:9347381. doi: 10.1155/2024/9347381. eCollection 2024. Biomed Res Int. 2024. PMID: 39445208 Free PMC article.
-
Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients.J Exp Clin Cancer Res. 2024 May 15;43(1):146. doi: 10.1186/s13046-024-03065-0. J Exp Clin Cancer Res. 2024. PMID: 38750579 Free PMC article. Review.
-
Analysis of early diagnostic pathway for prostate cancer in Slovenia.Radiol Oncol. 2024 Oct 4;58(4):544-555. doi: 10.2478/raon-2024-0046. eCollection 2024 Dec 1. Radiol Oncol. 2024. PMID: 39362037 Free PMC article.
References
-
- Holtedahl K, Vedsted P, Borgquist L, Donker GA, Buntinx F, Weller D, et al. Abdominal symptoms in general practice: frequency, cancer suspicions raised, and actions taken by GPs in six European countries. cohort study with prospective registration of cancer. Heliyon. 2017;3(6):e00328. doi: 10.1016/j.heliyon.2017.e00328. - DOI - PMC - PubMed
-
- Holtedahl K, Borgquist L, Donker GA, Buntinx F, Weller D, Campbell C, et al. Symptoms and signs of colorectal cancer, with differences between proximal and distal colon cancer: a prospective cohort study of diagnostic accuracy in primary care. BMC Fam Pract. 2021;22(1):148. doi: 10.1186/s12875-021-01452-6. - DOI - PMC - PubMed
-
- Suspected cancer: recognition and referral. NICE guideline [NG12]. London: National Institute for Health and Care Excellence; 2015. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical